Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I

Abstract

This trial demonstrates the long-term clinical benefit and safety of laronidase in attenuated patients with mucopolysaccharidosis I and highlights the magnitude and chronology of treatment effects. Prompt diagnosis and early treatment will maximize treatment outcomes.